Health Costs

Affordability and Spending

Beyond the Data: Are the Tradeoffs from Prior Authorization Worth It? 

In his latest column, President and CEO Dr. Drew Altman asks if prior authorization review could be eliminated entirely, discussing how it might be done and the tradeoffs. He writes “Nothing makes American health care consumers more frustrated using the health system than prior authorization review. I know because they told us that, ranking prior authorization review far ahead of any other problems they have getting care and navigating the health care system, including getting appointments and understanding their bills.”

Affordable care act

ACA Marketplace Survey Feature Image - Website

Cost Concerns and Coverage Changes: A Follow-Up Survey of ACA Marketplace Enrollees

This KFF survey is a follow-up survey of adults who had ACA Marketplace insurance in 2025. The survey examines the cost concerns and coverage changes that these 2025 Marketplace enrollees are experiencing following the expiration of the enhanced premium tax credits. The survey finds that half of returning enrollees say their health care costs are “a lot higher” and most expect to cut back on basic household expenses to afford coverage.

Health System Tracker

How Does Health Spending in the U.S. Compare to Other Countries? While the U.S. still spends the most in total dollars, eight OECD nations had a higher percentage increase in per-person health spending in 2024.

 

How Does Cost Affect Access to Health Care? In 2024, about 1 in 6 adults reported delaying or not getting healthcare due to cost, including medical or mental health care.

 

How Do Health Expenditures Vary Across the Population? Five percent of the population made up nearly half of all health spendings, pending an average of $72,918 annually in 2023.

NHE explorer

National Health Spending Explorer: Get up-to-date information on U.S. health spending by federal and local governments, private companies, and individuals.

Filter

1,331 - 1,340 of 1,564 Results

  • Retiree Health Benefits Now and In the Future – Chartpack

    Report

    This chartpack (charts used at the briefing releasing this survey), from the survey conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003, provides detailed information on retiree health programs offered by large private-sector employers.

  • Retiree Health Benefits in 2003: Employer Survey

    Report

    This survey, conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003 provides detailed information on retiree health programs offered by large private-sector employers.

  • Retiree Health Benefits Now and in the Future, Report

    Report

    Retiree Health Benefits Now and In the Future - Report This survey, conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003 provides detailed information on retiree health programs offered by large private-sector employers.

  • Cost of Health Insurance: Section 1 – Page 3

    Report

    Employer Health Benefits 2003 Annual Survey View All Charts for This Section Monthly Premium Costs of Single and Family Coverage In 2003, average monthly premiums for single and family coverage (including worker and employer share of premium) are $282 and $756 respectively (Exhibit 1.12). The cost of family coverage is now nearly $9,100 per year.

  • Kaiser/HRET Survey: 2002 State Employee Health Plans

    Report

    Kaiser/HRET Survey: 2002 State Employee Health Plans State employee health plans provided coverage for 3.4 million state government employees in 2002. The Kaiser/HRET Survey: 2002 State Employee Health Plans finds that premiums for state employee health plans increased 12.8% in 2002, similar to national averages.

  • Impact of Direct-to-Consumer Advertising on Prescription Drug Spending

    Report

    A new study by researchers at Harvard University and the Massachusetts Institute of Technology looks at the effect of direct-to-consumer (DTC) advertising on spending for prescription drugs. The study found that, on average, a 10% increase in DTC advertising of drugs within a therapeutic drug class resulted in a 1% increase in sales of the drugs in that class.

  • Demand Effects of Recent Changes in Prescription Drug Promotion

    Report

    The rapid increase in DTC advertising for prescription drugs has focused attention on its role in drug spending and prescribing. A new study by researchers at Harvard University and the Massachusetts Institute of Technology looks at the effect of direct-to-consumer (DTC) advertising on spending for prescription drugs.